false Q2 --12-31 2024-06-30 2024 6-K 0001786286 0001786286 2024-01-01 2024-06-30 0001786286 2024-06-30 0001786286 2023-12-31 0001786286 2024-04-01 2024-06-30 0001786286 2023-04-01 2023-06-30 0001786286 2023-01-01 2023-06-30 0001786286 ifrs-full:IssuedCapitalMember 2022-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2022-12-31 0001786286 ifrs-full:RetainedEarningsMember 2022-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2022-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-12-31 0001786286 2022-12-31 0001786286 ifrs-full:IssuedCapitalMember 2023-06-30 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-06-30 0001786286 ifrs-full:RetainedEarningsMember 2023-06-30 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2023-06-30 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-06-30 0001786286 2023-06-30 0001786286 ifrs-full:IssuedCapitalMember 2023-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-12-31 0001786286 ifrs-full:RetainedEarningsMember 2023-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2023-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-12-31 0001786286 ifrs-full:IssuedCapitalMember 2023-01-01 2023-06-30 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-01-01 2023-06-30 0001786286 ifrs-full:RetainedEarningsMember 2023-01-01 2023-06-30 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2023-01-01 2023-06-30 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-01-01 2023-06-30 0001786286 ifrs-full:IssuedCapitalMember 2023-07-01 2023-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-07-01 2023-12-31 0001786286 ifrs-full:RetainedEarningsMember 2023-07-01 2023-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2023-07-01 2023-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-07-01 2023-12-31 0001786286 2023-07-01 2023-12-31 0001786286 ifrs-full:IssuedCapitalMember 2024-01-01 2024-06-30 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-01-01 2024-06-30 0001786286 ifrs-full:RetainedEarningsMember 2024-01-01 2024-06-30 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2024-01-01 2024-06-30 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-01-01 2024-06-30 0001786286 ifrs-full:IssuedCapitalMember 2024-06-30 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-06-30 0001786286 ifrs-full:RetainedEarningsMember 2024-06-30 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2024-06-30 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-06-30 0001786286 DPRO:DragonflyInnovationsIncMember 2024-01-01 2024-06-30 0001786286 DPRO:DraganflyInnovationsUSAIncMember 2024-01-01 2024-06-30 0001786286 DPRO:DronelogicsSystemsIncMember 2024-01-01 2024-06-30 0001786286 DPRO:InventoryMember 2024-04-01 2024-06-30 0001786286 DPRO:InventoryMember 2023-04-01 2023-06-30 0001786286 DPRO:InventoryMember 2024-01-01 2024-06-30 0001786286 DPRO:InventoryMember 2023-01-01 2023-06-30 0001786286 DPRO:PublicCompanySharesMember 2024-06-30 0001786286 DPRO:PrivateCompanySharesMember 2024-06-30 0001786286 DPRO:PubliclyListedCompanyMember 2024-01-01 2024-06-30 0001786286 DPRO:PrivateCompanyMember 2024-01-01 2024-06-30 0001786286 ifrs-full:ComputerEquipmentMember 2022-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2022-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2022-12-31 0001786286 ifrs-full:VehiclesMember 2022-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2023-01-01 2023-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2023-01-01 2023-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:VehiclesMember 2023-01-01 2023-12-31 0001786286 2023-01-01 2023-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2023-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2023-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2023-12-31 0001786286 ifrs-full:VehiclesMember 2023-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2024-01-01 2024-06-30 0001786286 DPRO:FurnitureAndEquipmentMember 2024-01-01 2024-06-30 0001786286 ifrs-full:LeaseholdImprovementsMember 2024-01-01 2024-06-30 0001786286 ifrs-full:VehiclesMember 2024-01-01 2024-06-30 0001786286 ifrs-full:ComputerEquipmentMember 2024-06-30 0001786286 DPRO:FurnitureAndEquipmentMember 2024-06-30 0001786286 ifrs-full:LeaseholdImprovementsMember 2024-06-30 0001786286 ifrs-full:VehiclesMember 2024-06-30 0001786286 ifrs-full:BuildingsMember 2022-12-31 0001786286 ifrs-full:LandMember 2022-12-31 0001786286 ifrs-full:BuildingsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:LandMember 2023-01-01 2023-12-31 0001786286 ifrs-full:BuildingsMember 2023-12-31 0001786286 ifrs-full:LandMember 2023-12-31 0001786286 ifrs-full:BuildingsMember 2024-01-01 2024-06-30 0001786286 ifrs-full:LandMember 2024-01-01 2024-06-30 0001786286 ifrs-full:BuildingsMember 2024-06-30 0001786286 ifrs-full:LandMember 2024-06-30 0001786286 ifrs-full:LandMember DPRO:LeaseOneMember 2023-01-01 2023-12-31 0001786286 ifrs-full:BuildingsMember DPRO:LeaseTwoMember 2023-01-01 2023-12-31 0001786286 DPRO:LeaseOneFacilitiesMember 2024-01-01 2024-06-30 0001786286 DPRO:LeaseTwoFacilitiesMember 2024-01-01 2024-06-30 0001786286 DPRO:LeaseThreeFacilitiesMember 2024-01-01 2024-06-30 0001786286 DPRO:LeaseFourFacilitiesMember 2024-01-01 2024-06-30 0001786286 ifrs-full:BottomOfRangeMember 2024-06-30 0001786286 ifrs-full:TopOfRangeMember 2024-06-30 0001786286 ifrs-full:NotLaterThanOneYearMember 2024-06-30 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember 2024-06-30 0001786286 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2024-06-30 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2024-06-30 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2023-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2024-01-01 2024-06-30 0001786286 DPRO:CanadaEmergencyBusinessAccountLoanMember 2024-06-30 0001786286 DPRO:CanadaEmergencyBusinessAccountLoanMember 2023-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountLoanMember 2024-01-01 2024-06-30 0001786286 DPRO:VehicleLoanMember 2024-06-30 0001786286 DPRO:VehicleLoanMember 2023-12-31 0001786286 DPRO:VehicleLoanMember 2024-01-01 2024-06-30 0001786286 DPRO:CommonStock1Member 2024-01-01 2024-06-30 0001786286 DPRO:USDPrefundedWarrantsMember 2024-06-30 0001786286 DPRO:USDPrefundedWarrantsMember 2024-01-01 2024-06-30 0001786286 DPRO:CommonSharesMember DPRO:USDPrefundedWarrantsMember 2024-01-01 2024-06-30 0001786286 ifrs-full:WarrantsMember DPRO:USDPrefundedWarrantsMember 2024-01-01 2024-06-30 0001786286 DPRO:USDPrefundedWarrantsMember 2024-05-01 0001786286 DPRO:USDPrefundedWarrantsMember 2024-10-30 0001786286 DPRO:CADPrefundedWarrantsMember 2024-06-30 0001786286 DPRO:CADPrefundedWarrantsMember 2024-01-01 2024-06-30 0001786286 DPRO:CommonSharesMember DPRO:CADPrefundedWarrantsMember 2024-01-01 2024-06-30 0001786286 ifrs-full:WarrantsMember DPRO:CADPrefundedWarrantsMember 2024-01-01 2024-06-30 0001786286 DPRO:CommonStock1Member 2023-01-01 2023-12-31 0001786286 DPRO:CommonSharesMember 2023-01-01 2023-12-31 0001786286 DPRO:CommonSharesMember 2023-12-31 0001786286 DPRO:StockOptionsMember 2024-04-01 2024-06-30 0001786286 DPRO:StockOptionsMember 2023-04-01 2023-06-30 0001786286 DPRO:StockOptionsMember 2024-01-01 2024-06-30 0001786286 DPRO:StockOptionsMember 2023-01-01 2023-06-30 0001786286 DPRO:RestrictedStockUnitsMember 2024-04-01 2024-06-30 0001786286 DPRO:RestrictedStockUnitsMember 2023-04-01 2023-06-30 0001786286 DPRO:RestrictedStockUnitsMember 2024-01-01 2024-06-30 0001786286 DPRO:RestrictedStockUnitsMember 2023-01-01 2023-06-30 0001786286 ifrs-full:WarrantsMember 2024-01-01 2024-06-30 0001786286 ifrs-full:WarrantsMember country:CA 2024-01-01 2024-06-30 0001786286 ifrs-full:WarrantsMember 2023-01-01 2023-06-30 0001786286 DPRO:BrokerWarrantsMember 2024-01-01 2024-06-30 0001786286 DPRO:BrokerWarrantsMember country:CA 2024-01-01 2024-06-30 0001786286 DPRO:BrokerWarrantsMember 2023-01-01 2023-06-30 0001786286 DPRO:ExercisePriceOneMember DPRO:IncentiveShareCompensationPlanMember 2024-01-01 2024-06-30 0001786286 DPRO:ExercisePriceOneMember DPRO:IncentiveShareCompensationPlanMember 2024-06-30 0001786286 DPRO:ExercisePriceTwoMember DPRO:IncentiveShareCompensationPlanMember 2024-01-01 2024-06-30 0001786286 DPRO:ExercisePriceTwoMember DPRO:IncentiveShareCompensationPlanMember 2024-06-30 0001786286 DPRO:ExercisePriceThreeMember DPRO:IncentiveShareCompensationPlanMember 2024-01-01 2024-06-30 0001786286 DPRO:ExercisePriceThreeMember DPRO:IncentiveShareCompensationPlanMember 2024-06-30 0001786286 DPRO:ExercisePriceFourMember DPRO:IncentiveShareCompensationPlanMember 2024-01-01 2024-06-30 0001786286 DPRO:ExercisePriceFourMember DPRO:IncentiveShareCompensationPlanMember 2024-06-30 0001786286 DPRO:ExercisePriceFiveMember DPRO:IncentiveShareCompensationPlanMember 2024-01-01 2024-06-30 0001786286 DPRO:ExercisePriceFiveMember DPRO:IncentiveShareCompensationPlanMember 2024-06-30 0001786286 DPRO:ExercisePriceSixMember DPRO:IncentiveShareCompensationPlanMember 2024-01-01 2024-06-30 0001786286 DPRO:ExercisePriceSixMember DPRO:IncentiveShareCompensationPlanMember 2024-06-30 0001786286 DPRO:ExercisePriceSevenMember DPRO:IncentiveShareCompensationPlanMember 2024-01-01 2024-06-30 0001786286 DPRO:ExercisePriceSevenMember DPRO:IncentiveShareCompensationPlanMember 2024-06-30 0001786286 DPRO:ExercisePriceEightMember DPRO:IncentiveShareCompensationPlanMember 2024-01-01 2024-06-30 0001786286 DPRO:ExercisePriceEightMember DPRO:IncentiveShareCompensationPlanMember 2024-06-30 0001786286 DPRO:ExercisePriceNineMember DPRO:IncentiveShareCompensationPlanMember 2024-01-01 2024-06-30 0001786286 DPRO:ExercisePriceNineMember DPRO:IncentiveShareCompensationPlanMember 2024-06-30 0001786286 DPRO:ExercisePriceTenMember DPRO:IncentiveShareCompensationPlanMember 2024-01-01 2024-06-30 0001786286 DPRO:ExercisePriceTenMember DPRO:IncentiveShareCompensationPlanMember 2024-06-30 0001786286 DPRO:ExercisePriceElevenMember DPRO:IncentiveShareCompensationPlanMember 2024-01-01 2024-06-30 0001786286 DPRO:ExercisePriceElevenMember DPRO:IncentiveShareCompensationPlanMember 2024-06-30 0001786286 DPRO:IncentiveShareCompensationPlanMember 2024-06-30 0001786286 DPRO:RestrictedStockUnitsMember 2022-12-31 0001786286 DPRO:RestrictedStockUnitsMember 2023-01-01 2023-12-31 0001786286 DPRO:RestrictedStockUnitsMember 2023-12-31 0001786286 DPRO:RestrictedStockUnitsMember 2024-06-30 0001786286 ifrs-full:WarrantsMember 2022-12-31 0001786286 ifrs-full:WarrantsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:WarrantsMember 2023-12-31 0001786286 ifrs-full:WarrantsMember 2024-01-01 2024-06-30 0001786286 ifrs-full:WarrantsMember 2024-06-30 0001786286 DPRO:Range1Member 2024-01-01 2024-06-30 0001786286 DPRO:Range1Member 2024-06-30 0001786286 DPRO:Range1Member 2023-12-31 0001786286 DPRO:Range2Member 2024-01-01 2024-06-30 0001786286 DPRO:Range2Member 2024-06-30 0001786286 DPRO:Range2Member 2023-12-31 0001786286 DPRO:Range3Member 2024-01-01 2024-06-30 0001786286 DPRO:Range3Member 2024-06-30 0001786286 DPRO:Range3Member 2023-12-31 0001786286 DPRO:Range4Member 2024-01-01 2024-06-30 0001786286 DPRO:Range4Member 2024-06-30 0001786286 DPRO:Range4Member 2023-12-31 0001786286 DPRO:Range5Member 2024-01-01 2024-06-30 0001786286 DPRO:Range5Member 2024-06-30 0001786286 DPRO:Range5Member 2023-12-31 0001786286 DPRO:Range6Member 2024-01-01 2024-06-30 0001786286 DPRO:Range6Member 2024-06-30 0001786286 DPRO:Range6Member 2023-12-31 0001786286 2024-05-21 2024-05-21 0001786286 DPRO:NonadjustingEventsAfterReportingPeriodMember 2024-07-23 2024-07-23 0001786286 ifrs-full:WarrantsMember 2024-01-01 2024-06-30 0001786286 ifrs-full:WarrantsMember 2023-01-01 2023-12-31 0001786286 ifrs-full:WarrantsMember ifrs-full:BottomOfRangeMember 2024-01-01 2024-06-30 0001786286 ifrs-full:WarrantsMember ifrs-full:TopOfRangeMember 2024-01-01 2024-06-30 0001786286 ifrs-full:WarrantsMember 2022-12-31 0001786286 ifrs-full:WarrantsMember 2023-12-31 0001786286 ifrs-full:WarrantsMember 2024-06-30 0001786286 DPRO:WarrantOneMember 2024-01-01 2024-06-30 0001786286 DPRO:WarrantOneMember 2024-06-30 0001786286 DPRO:WarrantTwoMember 2024-01-01 2024-06-30 0001786286 DPRO:WarrantTwoMember 2024-06-30 0001786286 DPRO:WarrantThreeMember 2024-01-01 2024-06-30 0001786286 DPRO:WarrantThreeMember 2024-06-30 0001786286 DPRO:WarrantFourMember 2024-01-01 2024-06-30 0001786286 DPRO:WarrantFourMember 2024-06-30 0001786286 DPRO:WarrantFiveMember 2024-01-01 2024-06-30 0001786286 DPRO:WarrantFiveMember 2024-06-30 0001786286 DPRO:WarrantSixMember 2024-01-01 2024-06-30 0001786286 DPRO:WarrantSixMember 2024-06-30 0001786286 DPRO:WarrantSevenMember 2024-01-01 2024-06-30 0001786286 DPRO:WarrantSevenMember 2024-06-30 0001786286 DPRO:WarrantEightMember 2024-01-01 2024-06-30 0001786286 DPRO:WarrantEightMember 2024-06-30 0001786286 DPRO:WarrantNineMember 2024-01-01 2024-06-30 0001786286 DPRO:WarrantNineMember 2024-06-30 0001786286 DPRO:DronesMember 2024-01-01 2024-06-30 0001786286 DPRO:VitalMember 2024-01-01 2024-06-30 0001786286 DPRO:CorporatesMember 2024-01-01 2024-06-30 0001786286 DPRO:DronesMember 2023-01-01 2023-06-30 0001786286 DPRO:VitalMember 2023-01-01 2023-06-30 0001786286 DPRO:CorporatesMember 2023-01-01 2023-06-30 0001786286 country:CA 2024-06-30 0001786286 country:CA 2023-12-31 0001786286 country:US 2024-06-30 0001786286 country:US 2023-12-31 0001786286 country:CA 2024-04-01 2024-06-30 0001786286 country:CA 2023-04-01 2023-06-30 0001786286 country:CA 2024-01-01 2024-06-30 0001786286 country:CA 2023-01-01 2023-06-30 0001786286 country:US 2024-04-01 2024-06-30 0001786286 country:US 2023-04-01 2023-06-30 0001786286 country:US 2024-01-01 2024-06-30 0001786286 country:US 2023-01-01 2023-06-30 0001786286 DPRO:CEOAndDirectorMember 2024-04-01 2024-06-30 0001786286 DPRO:CEOAndDirectorMember 2023-04-01 2023-06-30 0001786286 DPRO:CEOAndDirectorMember 2024-01-01 2024-06-30 0001786286 DPRO:CEOAndDirectorMember 2023-01-01 2023-06-30 0001786286 DPRO:CEOMember 2024-04-01 2024-06-30 0001786286 DPRO:CEOMember 2023-04-01 2023-06-30 0001786286 DPRO:CEOMember 2024-01-01 2024-06-30 0001786286 DPRO:CEOMember 2023-01-01 2023-06-30 0001786286 DPRO:PresidentAndDirectorMember 2024-04-01 2024-06-30 0001786286 DPRO:PresidentAndDirectorMember 2023-04-01 2023-06-30 0001786286 DPRO:PresidentAndDirectorMember 2024-01-01 2024-06-30 0001786286 DPRO:PresidentAndDirectorMember 2023-01-01 2023-06-30 0001786286 ifrs-full:OtherRelatedPartiesMember 2024-04-01 2024-06-30 0001786286 ifrs-full:OtherRelatedPartiesMember 2023-04-01 2023-06-30 0001786286 ifrs-full:OtherRelatedPartiesMember 2024-01-01 2024-06-30 0001786286 ifrs-full:OtherRelatedPartiesMember 2023-01-01 2023-06-30 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2024-06-30 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2024-06-30 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001786286 ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember 2024-01-01 2024-06-30 0001786286 ifrs-full:HistoricalVolatilityForSharesMeasurementInputMember 2023-01-01 2023-12-31 0001786286 DPRO:NonadjustmentEventsMember DPRO:OctoberIssuanceMember 2024-08-07 0001786286 DPRO:NonadjustmentEventsMember DPRO:AprilIssuanceMember 2024-08-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:CAD xbrli:shares

 

Exhibit 99.1

 

 

Draganfly Inc.

 

Condensed Consolidated Interim Financial Statements - Unaudited

 

For the Three and Six Months Ended June 30, 2024

 

(Expressed in Canadian Dollars)

 

 
 

 

Draganfly Inc.

Condensed Consolidated Interim Statements of Financial Position - Unaudited

Expressed in Canadian Dollars

 

      June 30,   December 31, 
As at  Notes  2024   2023 
            
ASSETS             
Current Assets             
Cash  4  $5,290,547   $3,093,612 
Receivables  5   878,389    649,612 
Inventory  6   1,576,129    1,596,536 
Prepaids and Deposits  7   645,618    1,342,215 
 Total current assets      8,390,683    6,681,975 
              
Equipment  9   572,529    680,801 
Intangible assets      50,783    56,426 
Investments  8   179,727    189,403 
Receivable  5   156,200    - 
Right of use assets  10   550,617    721,687 
TOTAL ASSETS     $9,900,539   $8,330,292 
              
LIABILITIES AND SHAREHOLDERS’ EQUITY             
Current Liabilities             
Trade payables and accrued liabilities  12,19  $2,312,709   $2,638,981 
Customer deposits      110,993    104,715 
Deferred income  13   9,239    12,112 
Loans payable  14   1,686    85,058 
Derivative liability  15   9,382,960    4,196,125 
Lease liabilities  11   264,036    362,001 
 Total current liabilities      12,081,623    7,398,992 
              
Non-current Liabilities             
Deferred Income  13   86,567    95,562 
Lease liabilities  11   354,486    428,022 
TOTAL LIABILITIES      12,522,676    7,922,576 
              
SHAREHOLDERS’ EQUITY (DEFICIT)             
Share capital  15   102,448,909    97,070,976 
Reserve – share-based payments  15   7,444,407    6,870,139 
Accumulated deficit      (112,543,713)   (103,588,356)
Accumulated other comprehensive income      28,260    54,957 
TOTAL SHAREHOLDERS’ EQUITY (DEFICIT)      (2,622,137)   407,716 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)     $9,900,539   $8,330,292 

 

Nature and Continuance of Operations (Note 1)

Subsequent event (Note 21)

 

Approved and authorized for issuance by the Board of Directors on August 13, 2024.

 

“Scott Larson”   “Cameron Chell”
Director   Director

 

 2
 

 

Draganfly Inc.

Condensed Consolidated Interim Statements of Comprehensive loss - Unaudited

Expressed in Canadian Dollars

 

                        
      For the three months ended   For the six months ended 
      June 30, 2024   June 30, 2023   June 30, 2024   June 30, 2023 
                    
Sales of goods  16  $1,387,350   $1,581,358   $2,625,298   $2,962,174 
Provision of services  16   345,640    317,681    437,273    538,351 
TOTAL REVENUE      1,732,990    1,899,039    3,062,571    3,500,525 
                        
COST OF SALES  6   (1,271,317)   (1,431,922)   (2,320,886)   (2,589,974)
                        
GROSS PROFIT      461,673    467,117    741,685    910,551 
                        
OPERATING EXPENSES                       
Amortization     $2,821   $8,990   $5,643   $17,979 
Depreciation  9,10   141,559    166,737    284,681    224,243 
Director fees  19   91,463    151,577    243,900    303,240 
Insurance      355,705    508,424    719,980    1,006,430 
Office and miscellaneous  17   521,161    1,437,404    867,430    4,238,056 
Professional fees      888,480    1,573,887    1,468,740    2,421,074 
Research and development      191,068    555,460    312,459    1,348,684 
Share-based payments  15,19   305,147    478,915    504,054    1,019,478 
Travel      76,911    204,324    116,931    293,586 
Wages and salaries  19   1,821,608    2,148,317    3,403,039    3,969,398 
 Total operating expenses      (4,395,923)   (7,234,035)   (7,926,857)   (14,842,168)
OTHER INCOME (EXPENSE)                       
Change in fair value of derivative liability  15   (2,604,394)   -    (786,825)   57,314 
Finance and other gain      41,980    10,891    46,805    46,752 
Foreign exchange gain (loss)      7,823    (174,919)   74,560    (193,075)
Gain (loss) on disposal of assets      (19,226)   (5,508)   24,302    15,695 
Gain (loss) on recovery (impairment) of notes receivable      4,110    -    10,861    - 
Government income      -    1,297    -    2,572 
Other income (expense)  18   (587,592)   26,193    (1,139,888)   25,769 
 Total Other income (expenses)     $(3,157,299)  $(142,046)  $(1,770,185)  $(44,973)
                        
NET INCOME (LOSS)     $(7,091,549)  $(6,908,964)  $(8,955,357)  $(13,976,590)
OTHER COMPREHENSIVE INCOME (LOSS)                       
Items that may be reclassified to profit or loss                       
Foreign exchange translation      (7,459)   (21,775)   (17,021)   (108,177)
Items that will not be reclassified to profit or loss                       
Change in fair value of equity investments at FVOCI  8   1,370    39,927    (9,676)   96,960 
COMPREHENSIVE INCOME (LOSS)      (7,097,638)   (6,890,812)   (8,982,054)   (13,987,807)
                        
Net Income (Loss) per share – Basic & diluted     $(0.10)  $(0.16)  $(0.14)  $(0.36)
Weighted average number of common shares outstanding – Basic & diluted      70,654,779    43,195,602    62,794,276    38,965,859 

 

 3
 

 

Draganfly Inc.

Condensed Consolidated Interim Statements of Changes in Shareholders’ Equity - Unaudited

Expressed in Canadian Dollars

 

                                    
                   Accumulated Other
Comprehensive
Income (Loss)
     
   Number of
Shares
   Share
Capital
   Reserve –
Share-
Based
Payments
   Accumulated
Deficit
   Change in
Fair
Value of Investments
at FVTOCI
   Exchange
Differences on
Translation of
Foreign
Operations
   Total
Shareholders’
Equity (Deficit)
 
Balance at December 31, 2022   34,270,579   $83,600,089   $7,264,340   $(79,976,546)  $(431,123)  $584,121   $11,040,881 
Shares issued for financing – ATM (“At-the-Market”)   650,729    1,748,946    -    -    -                   -         1,748,946 
Share issue costs   -    (222,136)   -    -    -    -    (222,136)
Shares issued for financing   8,000,000    10,856,166    -    -    -    -    10,856,166 
Share issue costs   -    (1,707,128)   -    -    -    -    (1,707,128)
Shares issued for the exercise of RSUs   418,654    545,677    (545,677)   -    -    -    - 
Share-based payments   -    -    1,019,478    -    -    -    1,019,478 
Net loss   -    -    -    (13,976,590)   -    -    (13,976,590)
Change in fair value of equity investments at FVOCI   -    -    -    -    96,960    -    96,960 
Translation of foreign operations   -    -    -    -    -    (108,177)   (108,177)
Balance at June 30, 2023   43,339,962   $94,821,614   $7,738,141   $(93,953,136)  $(334,163)  $475,944   $8,748,400 
Shares issued for financing   4,800,000    520,064    -    -    -    -    520,064 
Share issue costs   -    (365,758)   224,868                   (140,890)
Shares issued for the exercise of RSUs   1,089,601    2,095,056    (2,095,056)   -    -    -    - 
Share-based payments   -    -    1,002,186    -    -    -    1,002,186 
Net loss   -    -    -    (9,635,220)   -    -    (9,635,220)
Change in fair value of equity investments at FVOCI   -    -    -    -    (100,140)   -    (100,140)
Translation of foreign operations   -    -    -    -    -    13,316    13,316 
Balance at December 31, 2023   49,229,563   $97,070,976   $6,870,139   $(103,588,356)  $(434,303)  $489,260   $407,716 
Shares issued for financing   18,263,514    2,414,103    -    -    -    -    2,414,103 
Share issue costs   -    (446,705)   227,045    -    -    -    (219,660)
Shares issued for the exercise of warrants   8,691,700    3,253,704    -    -    -    -    3,253,704 
Shares issued for the exercise of RSUs   114,992    156,831    (156,831)   -    -    -    - 
Shares returned to treasury   (900,000)   -    -    -    -    -    - 
Share-based payments   -    -    504,054    -    -    -    504,054 
Net loss   -    -    -    (8,955,357)   -    -    (8,955,357)
Change in fair value of equity investments at FVOCI   -    -    -    -    (9,676)   -    (9,676)
Translation of foreign operations   -    -    -    -    -    (17,021)   (17,021)
Balance at June 30, 2024   75,399,769   $102,448,909   $7,444,407   $(112,543,713)  $(443,979)  $472,239   $(2,622,137)

 

 4
 

 

Draganfly Inc.

Condensed Consolidated Interim Statements of Cash Flows - Unaudited

Expressed in Canadian Dollars

 

           
   For the six months ended June 30, 
   2024   2023 
         
OPERATING ACTIVITIES          
Net loss  $(8,955,357)  $(13,976,590)
Adjustments for:          
Amortization   5,643    17,979 
Depreciation   284,681    224,243 
Impairment of accounts receivable   -    198,513 
Change in fair value of derivative liability   786,825    (57,314)
Impairment of inventory   148,760    199,647 
Impairment (Gain) on recovery of notes receivable   (10,861)   - 
Finance and other costs   839,374    2,573 
Gain on disposal of assets   (24,302)   (15,695)
Share-based payments   504,054    1,019,478 
 Adjustments for profit loss   (6,421,183)   (12,387,166)
Net changes in non-cash working capital items:          
Receivables   (384,977)   882,164 
Inventory   (128,353)   (787,690)
Prepaids   696,597    959,434 
Trade payables and accrued liabilities   (157,841)   (208,099)
Customer deposits   6,278    (82,354)
Deferred income   (11,868)   (47,802)
Cash used in operating activities   (6,401,347)   (11,671,513)
           
INVESTING ACTIVITIES          
Purchase of equipment   (47,891)   (134,605)
Disposal of equipment   73,366    45,774 
Repayment of notes receivable   10,861    50,307 
Cash provided by (used in) investing activities   36,336    (38,524)
           
FINANCING ACTIVITIES          
Proceeds from issuance of common shares for financing   9,759,643    12,605,112 
Share issue costs   (1,298,367)   (1,929,264)
Proceeds from issuance of common shares for warrants exercised   371,500    - 
Repayment of loans   (83,372)   (3,373)
Repayment of lease liabilities   (170,437)   (27,918)
Cash provided by (used in) financing activities   8,578,967    10,644,557 
           
Effects of exchange rate changes on cash   (17,021)   (108,177)
Change in cash   2,213,956    (1,065,480)
Cash and cash equivalents, beginning of period   3,093,612    7,894,781 
Cash and cash equivalents, end of period  $5,290,547   $6,721,124 
           
SUPPLEMENTARY CASH FLOW DISCLOSURE          
Interest paid  $18,730   $49,021 
Share issue costs in accounts payable   114,432    246,836 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

 5
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Six Months Ended June 30, 2024

Expressed in Canadian Dollars (unaudited)

 

1. NATURE AND CONTINUANCE OF OPERATIONS

 

Draganfly Inc. (the “Company”) was incorporated on June 1, 2018 under the Business Corporations Act (British Columbia). The Company creates quality, cutting-edge unmanned and remote data collection and analysis platforms and systems that are designed to revolutionize the way companies do business. The Company’s shares trade on the Canadian Securities Exchange (the “CSE”), on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “DPRO” and on the Frankfurt Stock Exchange under the symbol “3U8A”. The Company’s head office is located at 235 103rd St. E, Saskatoon, SK, S7N 1Y8 and its registered office is located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z7.

 

These condensed consolidated interim financial statements have been prepared on the assumption that the Company will continue as a going concern, meaning it will continue in operation for the foreseeable future and will be able to realize assets and discharge liabilities in the ordinary course of operations. To date, the Company has not been profitable and has an accumulated deficit of $112,543,713. The Company’s ability to continue as a going concern is dependent upon its ability to obtain additional financing and or achieve profitable operations in the future. These factors raise substantial doubt over the Company’s ability to continue as a going concern. These condensed consolidated interim financial statements do not reflect adjustments that would be necessary if the going concern assumption were not appropriate. These adjustments could be material.

 

2. BASIS OF PREPARATION

 

Statement of Compliance

 

These condensed consolidated interim financial statements have been prepared in accordance with International Accounting Standard (“IAS”) 34, “Interim Financial Reporting”. These condensed consolidated interim financial statements include all necessary disclosures required for interim financial statements but do not include all disclosures required for annual financial statements. These condensed consolidated interim financial statements should be read in conjunction with the Company’s annual financial statements for the year ended December 31, 2023.

 

These condensed consolidated interim financial statements were authorized for issue by the Board of Directors on August 13, 2024.

 

Basis of consolidation

 

Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continues to be consolidated until the date when such control ceases.

 

The condensed consolidated interim financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:

 

Name of Subsidiary   Place of Incorporation   Ownership Interest
Draganfly Innovations Inc. (DII)   Canada   100%
Draganfly Innovations USA, Inc. (DI USA)   US   100%
Dronelogics Systems Inc. (“Dronelogics”)   Canada   100%

 

All intercompany balances and transactions were eliminated on consolidation.

 

 6
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Six Months Ended June 30, 2024

Expressed in Canadian Dollars (unaudited)

 

3. MATERIAL ACCOUNTING POLICY INFORMATION, ESTIMATES, AND JUDGEMENTS

 

These condensed consolidated interim financial statements have been prepared following the same accounting principles and methods of computation as in outlined in the Company’s consolidated financial statements for the year ended December 31, 2023. A description of the accounting standards and interpretations that have been adopted by the Company can be found in the notes of the annual financial statements for the year ended December 31, 2023.

 

The preparation of the condensed consolidated interim financial statements requires management to make assumptions and estimates that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of income and expenses during the reporting period. These condensed consolidated interim financial statements include estimates, which by their nature, are uncertain. These assumptions and associated estimates are based on historical experience and other factors that are considered to be relevant. As such, actual results may differ from estimates and the effect of such differences may be material. Significant estimates and judgements used in the preparation of these condensed consolidated interim financial statements remained unchanged from those disclosed in the Company’s annual consolidated financial statements for the year ended December 31, 2023.

 

4. CASH

 

As at  June 30, 2024   December 31, 2023 
Cash held in banks  $5,290,547   $3,093,612 

 

5. RECEIVABLES

 

As at  June 30, 2024   December 31, 2023 
Trade accounts receivable  $961,348   $610,443 
Sales tax receivable   73,241    39,169 
 Trade and other receivables  $1,034,589   $649,612 
Current portion  $878,389   $649,612 
Long term portion   156,200    - 
 Trade and other receivables  $1,034,589   $649,612 

 

During the six months ended June 30, 2024, the Company recorded a provision for doubtful accounts of $nil (2023 – $198,513).

 

The long-term receivable represents a refundable deposit that the Company has asked to have returned . The agreement allows for a two-year repayment term once the request has been made.

 

6. INVENTORY

 

As at  June 30, 2024   December 31, 2023 
Finished goods  $1,399,719   $904,858 
Parts   176,410    691,678 
 Inventories  $1,576,129   $1,596,536 

 

During the three and six months ended June 30, 2024, $1,177,811 (2023 - $1,259,183) and $2,144,150 (2023 – $2,272,064) of inventory was recognized in cost of sales respectively including an allowance to value its inventory for obsolete and slow-moving inventory of $134,410 (2023 -$77,047) and $283,169 (2023 - $199,647) respectively.

 

Cost of sales consist of the following:

 

For the six months ended  June 30, 2024   June 30, 2023 
Inventory  $2,144,150   $2,272,064 
Consulting and services   138,437    215,801 
Other   38,299    102,109 
 Cost of sales  $2,320,886   $2,589,974 

 

 7
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Six Months Ended June 30, 2024

Expressed in Canadian Dollars (unaudited)

 

7. PREPAIDS AND DEPOSITS

 

As at  June 30, 2024   December 31, 2023 
Insurance  $144,526   $838,445 
Prepaid other   121,326    142,124 
Deposits   379,766    361,646 
 Prepaid expenses and deposits  $645,618   $1,342,215 

 

8. INVESTMENTS

 

Balance at December 31, 2023  $189,403 
Change in fair value   (9,676)
Balance at June 30, 2024  $179,727 

 

Fair value of investments is comprised of:

Public company shares  $42,857 
Private company shares   136,780 
Balance at June 30, 2024  $179,727 

 

The Company holds 1,428,571 shares of a publicly listed company with an initial cost of $500,000.

 

The Company holds 50,000 common shares of a private company with an initial value of USD$100,000. The Company considers if observable market data exists on a quarterly basis to value the investment. Since inception, the Company has not had any adjustments to the fair value of the investment based on observable market data.

 

9. EQUIPMENT

 

   Computer
Equipment
   Furniture
and
Equipment
   Leasehold
Improvements
   Vehicles   Total 
Cost                         
Balance at December 31, 2022  $95,662   $834,453   $-   $36,033   $966,148 
Additions   58,611    320,943    86,530    24,310    490,394 
Disposals   (21,000)   (115,204)   -    -    (136,204)
Balance at December 31, 2023   133,273    1,040,192    86,530    60,343    1,320,338 
Additions   2,567    42,965    2,358    -    47,890 
Disposals   -    (128,615)   -    -    (128,615)
Balance at June 30, 2024  $135,840   $954,542   $88,888   $60,343   $1,239,613 
                          
Accumulated depreciation                         
Balance at December 31, 2022  $41,998   $502,790   $-   $16,669   $561,457 
Charge for the year   22,762    112,361    6,790    12,497    154,410 
Disposals   (6,582)   (69,748)   -    -    (76,330)
Balance at December 31, 2023   58,178    545,403    6,790    29,166    639,537 
Charge for the period   20,432    73,087    8,902    4,677    107,098 
Disposals   -    (79,551)   -    -    (79,551)
Balance at June 30, 2024  $78,610   $538,939   $15,692   $33,843   $667,084 
                          
Net book value:                         
December 31, 2023  $75,095   $494,789   $79,740   $31,177   $680,801 
June 30, 2024  $57,230   $415,603   $73,196   $26,500   $572,529 

 

 8
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Six Months Ended June 30, 2024

Expressed in Canadian Dollars (unaudited)

 

10. RIGHT OF USE ASSETS

 

   Vehicles   Buildings   Land   Total 
                 
Balance at December 31, 2022  $2,385   $342,361   $-   $344,746 
Additions   -    322,354    418,001    740,355 
Depreciation   (2,385)   (149,644)   (211,057)   (363,086)
Foreign exchange translation   -    -    (328)   (328)
Balance at December 31, 2023  $-   $515,071   $206,616   $721,687 
Depreciation  $-   $(71,364)  $(106,219)  $(177,583)
Foreign exchange translation   -    -    6,513    6,513 
Balance at June 30, 2024  $-   $443,707   $106,910   $550,617 

 

The Company added two new leases during the year ended December 31, 2023. A lease for land in the amount of $418,001 with an expiration date of December 31, 2024, and another lease for a facility in the amount of $322,354 with an expiration date of September 30, 2028. The Company has four leases with expiration dates of December 31, 2024, May 31, 2026, January 31, 2027, and September 30, 2028.

 

11.LEASE LIABILITIES

 

The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years. The leases are calculated using incremental borrowing rates ranging from 7.5% to 13.25%. Extension options are included in a majority of the leases with options that are only exercisable by the Company and not the other party.

 

As at  Total 
Balance at December 31, 2022  $378,643 
Interest expense   96,423 
Additions   734,903 
Lease payments   (423,410)
Foreign exchange translation   3,464 
Balance at December 31, 2023   790,023 
Interest expense   38,057 
Lease payments   (205,746)
Foreign exchange translation   (3,812)
Balance at June 30, 2024  $618,522 

 

Which consists of:

 

   June 30, 2024   December 31, 2023 
Current lease liability  $264,036   $362,001 
Non-current lease liability   354,486    428,022 
Ending balance  $618,522   $790,023 

 

Maturity analysis  Total 
Less than one year  $313,080 
One to three years   308,582 
Four to five years   93,387 
Total undiscounted lease liabilities   715,049 
Amount representing interest   (96,527)
Lease liability  $618,522 

 

 9
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Six Months Ended June 30, 2024

Expressed in Canadian Dollars (unaudited)

 

12. TRADE PAYABLES AND ACCRUED LIABILITIES

 

As at  June 30, 2024   December 31, 2023 
Trade accounts payable  $1,317,921   $1,259,623 
Accrued liabilities   961,079    1,345,649 
Government grant payable   33,709    33,709 
Trade payables and accrued liabilities  $2,312,709   $2,638,981 
13. DEFERRED INCOME

 

At times, the Company may take payment in advance for services to be rendered. These amounts are held and recognized as services are rendered.

 

As at  June 30, 2024   December 31, 2023 
Deferred income from customers  $-   $12,112 
Deferred income from government   95,806    95,562 
Deferred income gross  $95,806   $107,674 
Current portion  $9,239   $12,112 
Long-term portion   86,567    95,562 
Deferred income net  $95,806   $107,674 

 

Deferred revenue of $9,239 as of June 30, 2024 is expected to be recognized as revenue within one year. The remaining is related to a long-term support and maintenance arrangements and will be recognized according to the terms of these arrangements over the next 4.0 years.

 

14.LOANS PAYABLE

 

As at  June 30, 2024   December 31, 2023 
Opening balance  $85,058   $86,571 
Repayment of loans payable   (83,372)   (6,747)
Accretion expense   -    5,234 
Ending balance  $1,686   $85,058 

 

   Start Date  Maturity Date  Rate   Carrying
Value
June 30, 2024
   Carrying
Value
December 31, 2023
 
CEBA  2020-05-19  2024-03-28   0%  $-   $                 40,000 
CEBA  2021-04-23  2024-03-28   0%   -    40,000 
Vehicle loan  2019-08-30  2024-09-11   6.99%   1,686    5,058 
Total             $1,686   $85,058 

 

The CEBA loans are unsecured, and the vehicle loan is secured by the vehicle. The CEBA loans were repaid March 25, 2024.

 

 10
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Six Months Ended June 30, 2024

Expressed in Canadian Dollars (unaudited)

 

15.SHARE CAPITAL

 

Authorized share capital

 

Unlimited number of common shares without par value.

 

Issued share capital

 

During the six months ended June 30, 2024,

 

The Company issued 114,992 common shares for the vesting of restricted share units.
The Company issued 8,691,700 common shares for the exercise of warrants
The Company issued 11,200,000 units consisting of one common share and one warrant and 2,200,000 units consisting of one prefunded warrant and one warrant in a financing for $4,877,475 with share issuance costs of $752,498 for net proceeds of $4,124,977. Of the total share issuance costs $441,166 was expensed in other income (expense). The value of the issuance was allocated $2,017,966 to the shares, and $2,859,509 to the warrants, including $431,084 allocated to prefunded warrants. The prefunded warrants were exercised on the date of issue. May 1, 2024 the exercise price of the warrants was amended to CAD $0.3583 from the original exercise price of USD $0.6123 and the cashless exercise provision was removed. This amended exercise price is the Canadian equivalent of the USD trading price on October 30, 2024 of USD$ 0.259, the date of issue of these warrants.
900,000 shares were returned to treasury that were held in escrow related to the Vital Intelligence Inc. acquisition for failure to meet required milestones. All value that had been recorded related to these shares had been previously written off.
The Company issued 7,063,514 units consisting of one common share and one warrant and 6,450,000 units consisting of one prefunded warrant and one warrant in a financing for $4,818,952 with share issuance costs of $779,615 for net proceeds of $4,039,337. Of the total share issuance costs $671,747 was expensed in other income (expense). The value of the issuance was allocated $396,137 to the shares, and $4,422,815 to the warrants, including $1,248,343 allocated to prefunded warrants.

 

During the year ended December 31, 2023,

 

The Company issued 1,508,255 common shares for the vesting of restricted share units.
The Company issued 8,000,000 common shares in a financing for $10,856,166 with share issuance costs of $1,953,032 for net proceeds of $8,903,134.
The Company issued 650,729 common shares in an ATM (“At – the - market”) financing for $1,748,946 with share issuance costs of $222,136 for net proceeds of $1,526,810.
The Company issued 4,800,000 common shares in a financing for proceeds of $4,858,995 with share issuance costs of $889,623 for net proceeds of $3,969,372. Of the total share issuance costs $793,979 were expensed in other income (expense). Value of the issuance was allocated $520,064 to the shares and $4,338,931 to derivative liability.

 

Stock Options

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the CSE requirements, grant to directors, officers, employees, and technical consultants to the Company, non-transferable stock options to purchase common shares. The total number of common shares reserved and available for grant and issuance pursuant to this plan shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time. The number of options awarded and underlying vesting conditions are determined by the Board of Directors in its discretion.

 

 11
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Six Months Ended June 30, 2024

Expressed in Canadian Dollars (unaudited)

 

15. SHARE CAPITAL (CONT’D)

 

As at June 30, 2024, the Company had the following options outstanding and exercisable:

 

Grant Date  Expiry Date  Exercise
Price
   Remaining
Contractual
Life (years)
   Number of
Options
Outstanding
   Number of
Options
Exercisable
 
October 30, 2019  October 30, 2029  $2.50    5.57    278,332    278,332 
November 19, 2019  November 19, 2029  $2.50    5.63    50,000    50,000 
April 30, 2020  April 30, 2030  $2.50    6.07    10,000    10,000 
April 30, 2020  April 30, 2030  $3.85    6.07    110,000    110,000 
July 3, 2020  July 3, 2025  $3.20    1.25    100,000    100,000 
November 24, 2020  November 24, 2030  $2.50    6.64    32,000    32,000 
February 2, 2021  February 2, 2031  $13.20    6.83    30,000    30,000 
March 8, 2021  March 8, 2026  $13.90    1.93    10,000    10,000 
April 27, 2021  April 27, 2031  $10.15    7.06    132,665    132,665 
September 9, 2021  September 9, 2026  $4.84    2.44    25,826    17,217 
November 9, 2023  November 9, 2033  $0.626    9.59    30,000    10,000 
                 808,823    780,214 

 

   Number of
Options
   Weighted Average
Exercise Price
 
Outstanding, December 31, 2022   877,157   $4.60 
Forfeited   (9,999)   3.77 
Issued   30,000    0.63 
Outstanding, December 31, 2023   897,158   $4.48 
Forfeited   (88,335)   3.65 
Outstanding, June 30, 2024   808,823   $4.57 

 

No options were granted by the Company during the six months ended June 30, 2024.

 

During the three and six months ended June 30, 2024, the Company recorded $26,690 (2023 – $27,425) and $53,379 (2023 - $130,437) respectively in stock-based compensation in relation to the vesting of stock options. The fair values of stock options granted were estimated using the Black-Scholes Option Pricing Model.

 

Restricted Share Units

 

During the three and six months ended June 30, 2024, the Company recorded share-based payment expense of $278,457 (2023 - $451,490) and $420,340 (2023 - $889,041) for RSUs, based on the fair values of RSUs granted which were calculated using the closing price of the Company’s stock on the day prior to grant.

 

The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the Exchange requirements, grant to directors, officers, employees and technical consultants to the Company, restricted stock units (RSUs). The number of RSUs awarded and underlying vesting conditions are determined by the Board of Directors in its discretion. RSUs will have a 3-year vesting period following the award date. The total number of common shares reserved and available for grant and issuance pursuant to this plan, and the total number of Restricted Share Units that may be awarded pursuant to this plan, shall not exceed 15% (in the aggregate) of the issued and outstanding common shares from time to time.

 

 12
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Six Months Ended June 30, 2024

Expressed in Canadian Dollars (unaudited)

 

15. SHARE CAPITAL (CONT’D)

 

As at June 30, 2024, the Company had the following RSUs outstanding:

 

   Number of RSUs 
Outstanding, December 31, 2022   1,198,875 
Vested   (1,508,255)
Issued   1,685,316 
Forfeited   (262,969)
Outstanding, December 31, 2023   1,112,967 
Vested   (114,992)
Issued   4,630,443 
Forfeited   (64,237)
Outstanding, June 30, 2024   5,564,181 

 

Warrants

 

During the six months ended June 30, 2024 and the year ended December 31, 2023, the Company issued pre-funded warrants (“USD pre-funded Warrants”) where a portion of the funds related to the eventual exercise have already been received with the remaining exercise price in USD. As part of these same issuances, shares with warrants attached were issued. Being in a foreign currency that is not the Company’s functional currency and these pre-funded warrants were not issued in exchange for services, the value related to the future exercise price of the USD pre-funded Warrants are required to be recorded as a financial liability and not as equity. As a financial liability, the portion of the USD pre-funded Warrants related to the future exercise price will be revalued on a quarterly basis to fair market value with the change in fair value being recorded in profit or loss. The warrants issued with the shares are also in USD so are also accounted for as a liability. In addition, the Company also issued pre-funded warrants with an exercise price in Canadian dollars (“Pre-funded Warrants”). These are also treated as a liability as the agreement contains clauses that do not meet the fixed for fixed test. As a financial liability, the portion of the Pre-funded Warrants related to the future exercise price will be revalued on a quarterly basis to fair market value with the change in fair value being recorded in profit or loss. The warrants issued with the shares are also accounted for as a liability as these also contain clauses that do not meet the fixed for fixed test.

 

To reach a fair value of the warrants, a Black Scholes calculation is used, calculated in USD for those with a USD exercise price and in CAD for those with a Canadian exercise price. The Black Scholes value per warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period for those denominated in USD. At the dates of issue the warrants were valued with a risk free rate of 4.33% and 4.65% (2023 – 4.8%), volatility of 119.23% and 119.80% (2023 – 115.35%), expected life of 5 years and an expected dividend yield rate of 0%. The broker warrants were valued with a risk free rate of 4.48% and 4.62% (2023 – 4.87%), volatility of 107.8% and 108.67% (2023 – 138.83%), expected life of 3 years and an expected dividend yield of 0%.

 

Warrant Derivative Liability

 

Balance at December 31, 2022  $- 
Warrants issued   3,985,015 
Change in fair value of warrants outstanding   211,110 
Balance at December 31, 2023  $4,196,125 
Warrants issued   7,282,325 
Warrants exercised   (2,882,315)
Change in fair value of warrants outstanding   786,825 
Balance at June 30, 2024  $9,382,960 

 

 13
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Six Months Ended June 30, 2024

Expressed in Canadian Dollars (unaudited)

 

15. SHARE CAPITAL (CONT’D)

 

Details of these warrants and their fair values are as follows:

Issue Date  Exercise Price   Number of
Warrants
Outstanding at
June 30,
2024
   Fair
Value at
June 30,
2024
   Number of
Warrants
Outstanding at
December 31,
2023
(5)
   Fair
Value at
December 31,
2023
 
October 30, 2023 (1)  CAD$0.3583    6,400,000    1,622,425    6,400,000    3,180,543 
October 30, 2023 (2)  US$0.0001    -    -    1,600,000    1,015,582 
February 26, 2024 (3)  US$0.1761    11,859,300         3,216,492    -    - 
February 26, 2024 (4)  US$0.0001     -    -    -    - 
April 29, 2024 (5)  CAD$0.354    13,513,514    3,551,850    -    - 
April 29, 2024 (6)  CAD$0.00014    3,099,000    992,193    -    - 
         34,871,814   $9,382,960    8,000,000   $4,196,125 

 

1)The warrants expire October 30, 2028.
2)The warrants have no expiry date. They were exercised January 5, 2024.
3)The warrants expire February 26, 2029.
4)The warrants have no expiry date. They were exercised February 26, 2024.
5)The warrants expire April 29, 2029
6)The warrants have no expiry date. 3,351,000 of the total issue of 6,450,000 were exercised May 21, 2024 and 3,099,000 were exercised subsequent to June 30, 2024 on July 23, 2024.

 

The fair values of these warrants were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions:

 

   June 30, 2024   December 31, 2023 
Risk free interest rate   4.44%   3.84%
Expected volatility   119.23%   113.78%
Expected life   4.34.8 years    4.8 years 
Expected dividend yield   0%   0%

 

   Number of
Warrants
   Weighted Average
Exercise Price
 
Outstanding, December 31, 2022   7,916,797   $5.08 
Issued   8,320,000    0.50 
Expired   (7,661,999)   5.89 
Outstanding, December 31, 2023   8,574,798   $0.63 
Issued   36,909,190    0.23 
Exercised   (8,691,700)   0.0428 
Outstanding June 30, 2024   36,792,288   $0.39 

 

 14
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Six Months Ended June 30, 2024

Expressed in Canadian Dollars (unaudited)

 

15. SHARE CAPITAL (CONT’D)

 

As at June 30, 2024, the Company had the following warrants outstanding:

 

Date issued  Expiry date  Exercise price   Number of
warrants
outstanding
 
July 29, 2021  July 29, 2024  US$5.00    250,000 
September 14, 2021  September 14, 2024  US$5.00    4,798 
October 30, 2023  October 30, 2026  US$0.6875    320,000 
October 30, 2023  October 30, 2028  CAD$0.3583    6,400,000 
February 26, 2024  February 26, 2027  US$0.3375    670,000 
February 26, 2024  February 26, 2029  US$0.1761    11,859,300 
April 29, 2024  April 29, 2029  CAD$0.354    13,513,514 
April 29, 2024  April 29, 2024  CAD$0.00014    3,099,000 
April 29, 2024  April 29, 2024  CAD$0.4425    675,676 
            36,792,288 

 

The weighted average remaining contractual life of warrants outstanding as of June 30, 2024, was 4.43 years (December 31, 2023 – 4.63 years).

 

16. SEGMENTED INFORMATION

 

The Company organizes its three segments based on product lines as well as a Corporate segment. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. The Company aggregates the information for the segments by analyzing the revenue steam and allocating direct costs to that respective segment. The Corporate segment is aggregated by relying on the entity that includes corporate costs (Draganfly Inc.).

 

June 30, 2024  Drones   Vital   Corporate   Total 
Sales of goods  $2,625,298   $-   $-   $2,625,298 
Provision of services   437,273    -    -    437,273 
Total revenue   3,062,571    -    -    3,062,571 
Segment loss (income)   2,866,980    -    6,392,802    9,259,782 
Finance and other costs   46,805    -    -    46,805 
Depreciation   276,655    -    8,026    284,681 
Amortization   5,643    -    -    5,643 
Change in fair value of derivative liability   -    -    (786,825)   (786,825)
Loss on write-off of notes receivable   -    -    10,861    10,861 
Loss on write down of inventory   134,410    -    -    134,410 
Net loss for the period  $3,330,493   $-   $5,624,864   $8,955,357 

 

 15
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Six Months Ended June 30, 2024

Expressed in Canadian Dollars (unaudited)

 

16. SEGMENTED INFORMATION (CONT’D)

 

June 30, 2023  Drones   Vital   Corporate   Total 
Sales of goods  $2,962,174   $-   $-   $2,962,174 
Provision of services   538,351    -    -    538,351 
Total revenue   3,500,525    -    -    3,500,525 
Segment loss   8,972,201    153,641    4,512,945    13,638,787 
Finance and other costs   (43,689)   -    (3,063)   (46,752)
Depreciation   219,422    -    4,821    224,243 
Amortization   17,979    -    -    17,979 
Change in fair value of derivative liability   -    -    (57,314)   (57,314)
Loss on write-off of notes receivable   199,647    -    -    199,647 
Net loss for the period  $9,365,560   $153,641   $4,457,389   $13,976,590 

 

Geographic revenue is measured by aggregating sales based on the country and the entity where the sale was made.

 

         
Geographic segmentation is as follows:  As of December 31, 
   2024   2023 
Non-current assets          
Canada  $1,402,947   $1,441,701 
United States   106,909    206,616 
Non-current assets  $1,509,856   $1,648,317 

 

                 
Geographic segmentation is as follows:  For the three months ended
June 30,
   For the six months ended
June 30,
 
   2024   2023   2024   2023 
Revenue                    
Canada  $1,726,160   $1,899,039   $3,053,493   $3,491,133 
United States   6,830    -    9,078    9,392 
Revenue  $1,732,990   $1,899,039   $3,062,571   $3,500,525 

 

17. OFFICE AND MISCELLANEOUS

 

                 
   For the three months ended
June 30,
   For the six months ended
June 30,
 
   2024   2023   2024   2023 
Advertising, Marketing, and Investor Relations  $232,685   $951,659   $342,758   $3,287,712 
Compliance fees   74,967    108,328    138,999    135,635 
Impairment of accounts receivable   -    -    -    198,513 
Contract Work   -    47,082    -    114,429 
Other   213,509    330,335    385,673    501,767 
Office and Miscellaneous Expenses  $521,161   $1,437,404   $867,430   $4,238,056 

 

18. OTHER EXPENSE

 

                 
   For the three months ended
June 30,
   For the six months ended
June 30,
 
   2024   2023   2024   2023 
Share issue costs  $595,921   $   -   $1,194,450   $- 
Write off of accounts (payable) receivable   -    -    (48,833)   - 
Gain on settlement of debt   

-

    (26,193)        (26,193)
Other   (8,329)   -    (5,729)   424 
Total Other expenses  $587,592   $(26,193)  $1,139,888   $(25,769) 

 

 16
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Six Months Ended June 30, 2024

Expressed in Canadian Dollars (unaudited)

 

19. RELATED PARTY TRANSACTIONS

 

Trade receivables/payables and accrued receivables/payables:

 

As at June 30, 2024, the Company had $18,000 (2023 - $95,345) payable to related parties that was included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.

 

Key management compensation

 

Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. Compensation awarded to key management for the three and six months ended June 30, 2024 and 2023 included:

 

                 
   For the three months ended
June 30,
   For the six months ended
June 30,
 
   2024   2023   2024   2023 
Director fees  $91,463   $151,577   $243,900   $303,240 
Salaries   127,518    431,407    269,586    533,522 
Share-based payments   181,749    267,638    303,861    530,880 
Total   $400,730   $850,622   $817,347   $1,367,642 

 

During the three months ended June 30, 2024, the directors agreed to a 20% reduction in their fees for the first and second quarter resulting in an adjustment of $30,488 to the first quarter directors’ fees which flowed through the second quarter.

 

Other related party transactions

 

                 
   For the three months ended
June 30,
   For the six months ended
June 30,
 
   2024   2023   2024   2023 
Management fees paid to a company controlled by CEO and director  $65,702   $280,000   $125,702   $380,000 
Management fees paid to a company that the CEO holds an economic interest in   109,437    123,153    215,687    226,782 
Management fees paid to a company controlled by the former President and director   36,991    86,754    77,424    145,152 
Management fees paid to a company, total  $212,130   $489,907   $418,813   $751,934 

 

20. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT

 

The Company is exposed in varying degrees to a variety of financial instrument related risks. The Board of Directors approves and monitors the risk management processes, inclusive of documented investment policies, counterparty limits, and controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:

 

Credit risk

 

Credit risk is the risk that of an unexpected loss if a customer or third party fails to meet its contractual obligations.

 

The Company is subject to credit risk on its cash and receivables. The majority of cash is deposited in bank accounts held with a major bank in Canada and the United States. As most of the Company’s cash is held by one bank there is a concentration of credit risk. This risk is managed by using major banks that are high credit quality financial institutions as determined by rating agencies.

 

 17
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Six Months Ended June 30, 2024

Expressed in Canadian Dollars (unaudited)

 

20. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)

 

Receivables

 

Receivables primarily consist of trade receivables and taxes receivable. The Company provides credit in the normal course of business in the form of payment terms and has an established process for determining terms to offer customers to mitigate credit risk. Receivables are shown net of any provision made for impairment of the receivables. Due to this factor, the Company believes that no additional credit risk, beyond amounts provided for collection loss, is inherent in receivables.

 

Expected credit loss (“ECL”) analysis is performed at each reporting date using an objective approach to measure expected credit losses. The provision amounts are based on direct management interface with the customer. The calculations reflect the probability-weighted outcome, the time value of money and reasonable supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. Receivables are written off where there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, amongst others, business failure, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments over the negotiated contract period.

 

Trade receivables include balances of $229,077 that are past due with no corresponding allowance recorded. However, upon review of these balances,the expected credit loss rate for overdue balances is estimated to be nominal. A total of $126,027 of past due balances without allowances  booked against them has been collected subsequent to period end and $106,521 is being pursued by legal means for collection.

 

Fair value

 

A number of the Company’s accounting policies and disclosures require the measurement of fair values for financial assets and liabilities. The Company has established a control framework with respect to the measurement of fair values. Fair values are categorized into different levels of a fair value hierarchy based on the inputs used in the valuation techniques as follows:

 

Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.

 

Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.

 

Level 3: techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data.

 

Equity securities in investee companies and warrants are measured at fair value. The financial assets and liabilities measured at fair value by hierarchy are shown in the table below. The amounts shown are based on the amounts recognized in the condensed consolidated interim statements of financial position. These financial assets are measured at fair value through profit and loss.

 

June 30, 2024  Level 1   Level 3   Total 
Cash and cash equivalents  $5,290,547   $-   $5,290,547 
Equity securities in investee companies   42,857    136,870    179,727 
Derivative liability   -    9,382,960    9,382,960 
Total  $5,333,404   $9,519,830   $14,853,234 

 

December 31, 2023  Level 1   Level 3   Total 
Cash and cash equivalents  $3,093,612    -   $3,093,612 
Equity securities in investee companies  $57,143   $132,260   $189,403 
Derivative liability   -    4,196,125    4,196,125 
Total  $3,150,755   $4,328,385   $7,479,140 

 

 18
 

 

Draganfly Inc.

Notes to the Condensed Consolidated Interim Financial Statements

For the Three and Six Months Ended June 30, 2024

Expressed in Canadian Dollars (unaudited)

 

20. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)

 

The following table shows the valuation techniques used in measuring Level 3 fair values for the derivative liability as well as the significant unobservable inputs used.

 

Type   Valuation technique   Key inputs   Inter-relationship between significant inputs and fair value measurement
Warrant   The fair value of the  

Key observable inputs

 

The estimated fair value would increase

derivative   warrants derivative   Share price   (decrease) if:
liability   liability at initial   Risk free interest rate   The price was higher (lower)
  recognition and at   Dividend yield   The risk-free rate was higher (lower)
    year end has been   Key unobservable inputs   The dividend yield was lower (higher)
    calculated using the   Expected volatility   The expected volatility was higher (lower)
    Black Scholes        
    Option Pricing Model            

 

For the fair value of the derivative liability, reasonable possible changes to the expected volatility, the most significant unobservable input would have the following effects:

 

Unobservable Inputs  Change   Impact on comprehensive loss 
       Six months ended
June 30, 2024
   Year ended
December 31, 2023
 
Volatility   20%  $589,059   $291,149 

 

21. SUBSEQUENT EVENT

 

August 7, 2024 the terms of the remaining outstanding warrants from the October 2023 issuance of 6,400,000 and the remaining outstanding warrants from the April issuance of 13,513,514 were all amended such that they will be moved to equity presentation from the current liability presentation. The amendment updated the terms such that they are all now fixed-for-fixed.

 

 19